Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 87 of 95, showing 5 Applications out of 474 total, starting on record 431, ending on 435

# Protocol No Study Title Investigator(s) & Site(s)

431.

ECCT/23/11/06   MPZ-MAL-01
    A Phase 2a, Multicenter, Open-label, Dose-finding, Dose Escalation Study of Meplazumab in Adult Patients Diagnosed with Uncomplicated Plasmodium falciparum Malaria   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. AHERO CLINICAL TRIALS UNIT (Kisumu county)
2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
3. Kenya Medical Research Institute(KEMRI):Siaya Clinical Research Annex (Siaya county)
 
View

432.

ECCT/23/12/01   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Prof Walter Jaoko
2. Dr. Lucas Thina Otieno
3. Prof. Kariuki Simon
4. Dr. Janet Nyawira Oyieko
5. Walter Otieno
6. Onono Dr. Marcianah
7. Dr. Lucas Thina Otieno
8. Prof. Kariuki Simon
9. Dr. Janet Nyawira Oyieko
10. Walter Otieno
11. Onono Dr. Marcianah
Site(s) in Kenya
1. KAVI-Institute of Clinical Research, University of Nairobi (Nairobi City county)
2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
3. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
4. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
5. Siaya County Referral Hospital (SCRH (Siaya county)
6. Kenya Medical Research Institute Center for Microbiology Research (CMR (Kisumu county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
View

433.

ECCT/23/12/02   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Dr. Maricianah Onono
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
4. Siaya County Referral Hospital (SCRH) (Siaya county)
5. Kenya Medical Research Institute Center for Microbiology Research (CMR) (Kisumu county)
6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
View

434.

ECCT/23/12/03   CONSTELLATION
    A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum, B. infantis) supplementation versus placebo on weight gain in underweight infants   
Principal Investigator(s)
1. Dr Benson Ochieng Singa
Site(s) in Kenya
1. Migori County Referral Hospital (Migori county)
 
View

435.

ECCT/23/12/04   GBT021601 OLE
    An Open-label Extension Study to Evaluate the Long-term Safety of GBT021601 Administered to Participants with Sickle Cell Disease Who Have Participated in a GBT021601 Clinical Trial       
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
3. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Gertude\'s Children\'s Hospital (Nairobi City county)
2. CENTER FOR RESEARCH IN THERAPEUTIC SCIENCES-STRATHMORE UNIVERSITY MEDICAL CENTER (CREATES (Nairobi City county)
3. KENYA MEDICAL RESEARCH INSTITUTE- CENTER FOR RESPIRATORY DISEASE RESEARCH(CRDR) (Nairobi City county)
4. KEMRI CRDR SIAYA (Siaya county)
 
View